Confidence Interval Criteria for Assessment of Dose Proportionality
- 1 January 2000
- journal article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 17 (10), 1278-1283
- https://doi.org/10.1023/a:1026451721686
Abstract
Purpose. The aim of this work was a pragmatic, statistically sound and clinically relevant approach to dose-proportionality analyses that is compatible with common study designs. Methods. Statistical estimation is used to derive a (1-α)% confidence interval (CI) for the ratio of dose-normalized, geometric mean values (Rdnm) of a pharmacokinetic variable (PK). An acceptance interval for Rdnm defining the clinically relevant, dose-proportional region is established a priori. Proportionality is declared if the CI for Rdnm is completely contained within the critical region. The approach is illustrated with mixed-effects models based on a power function of the form PK = β0 • Doseβ1; however, the logic holds for other functional forms. Results. It was observed that the dose-proportional region delineated by a power model depends only on the dose ratio. Furthermore, a dose ratio (ρ1) can be calculated such that the CI lies entirely within the pre-specified critical region. A larger ratio (ρ2) may exist such that the CI lies completely outside that region. The approach supports inferences about the PK response that are not constrained to the exact dose levels studied. Conclusion. The proposed method enhances the information from a clinical dose-proportionality study and helps to standardize decision rules.Keywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics of Testosterone in Hypogonadal Men After Transdermal Delivery: Influence of DoseThe Journal of Clinical Pharmacology, 1996
- Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion.British Journal of Clinical Pharmacology, 1995
- Influence of Dose Range on Degree of Nonlinearity Detected in Dose-Proportionality Studies for Drugs with Saturable Elimination: Single-Dose and Steady-State StudiesPharmaceutical Research, 1993
- Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl MetaboliteThe Journal of Clinical Pharmacology, 1992
- Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral dosesAntimicrobial Agents and Chemotherapy, 1992
- Absolute Bioavailability and Dose Proportionality of Betaxolol in Normal Healthy SubjectsJournal of Pharmaceutical Sciences, 1988
- Area-dose relationships in nonlinear modelsJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973